Positive feedback of DDX6/c-Myc/PTB1 regulated by miR-124 contributes to maintenance of the Warburg effect in colon cancer cells

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 9, 2015, Pages 1971-1980

  Taniguchi, Kohei ^a,b   Sugito, Nobuhiko ^a   Kumazaki, Minami ^a   Shinohara, Haruka ^a   Yamada, Nami ^a   Matsuhashi, Nobuhisa ^c   Futamura, Manabu ^c   Ito, Yuko ^b   Otsuki, Yoshinori ^b   Yoshida, Kazuhiro ^c   Uchiyama, Kazuhisa ^b   Akao, Yukihiro ^a  

^a GIFU UNIVERSITY   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

C Myc; DDX6; MiR 124; PKM; PTBP1; Warburg effect

Indexed keywords

CASPASE 9; DDX6 PROTEIN; HOE 33342; MICRORNA 124; MYC PROTEIN; PROTEIN; PTB1 PROTEIN; PYRUVATE KINASE; RNA HELICASE; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL FUNCTION; CELL PROLIFERATION; CHROMATIN; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE CONTROL; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; MUSCLE; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; VERY ELDERLY; WARBURG EFFECT; WESTERN BLOTTING;

EID: 84937123266     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.06.022     Document Type: Article

References (38)

1. Akao Y., Seto M., Takahashi T., Saito M., Utsumi K.R., Nakazawa S., Ueda R. Rearrangements on chromosome 11q23 in hematopoietic tumor-associated t(11;14) and t(11;19) translocations. Cancer Res. 1991, 51:6708-6711.
2. Akao Y., Seto M., Yamamoto K., Iida S., Nakazawa S., Inazawa J., Abe T., Takahashi T., Ueda R. The RCK gene associated with t(11;14) translocation is distinct from the MLL/ALL-1 gene with t(4;11) and t(11;19) translocations. Cancer Res. 1992, 52:6083-6087.
3. Akao Y., Marukawa O., Morikawa H., Nakao K., Kamei M., Hachiya T., Tsujimoto Y. The rck/p54 candidate proto-oncogene product is a 54-kilodalton D-E-A-D box protein differentially expressed in human and mouse tissues. Cancer Res. 1995, 55:3444-3449.
4. Nakagawa Y., Morikawa H., Hirata I., Shiozaki M., Matsumoto A., Maemura K., Nishikawa T., Niki M., Tanigawa N., Ikegami M., Katsu K., Akao Y. Overexpression of rck/p54, a DEAD box protein, in human colorectal tumours. Br. J. Cancer 1999, 80:914-917.
5. Hashimoto K., Nakagawa Y., Morikawa H., Niki M., Egashira Y., Hirata I., Katsu K., Akao Y. Co-overexpression of DEAD box protein rck/p54 and c-myc protein in human colorectal adenomas and the relevance of their expression in cultured cell lines. Carcinogenesis 2001, 22:1965-1970.
6. Akao Y., Matsumoto K., Ohguchi K., Nakagawa Y., Yoshida H. Human DEAD-box/RNA unwindase rck/p54 contributes to maintenance of cell growth by affecting cell cycle in cultured cells. Int. J. Oncol. 2006, 29:41-48.
7. Akao Y. A role of DEAD-Box RNA helicase rck/p54 in cancer cells. Curr. Drug Ther. 2009, 4:29-37.
8. Matsui T., Hogetsu K., Usukura J., Sato T., Kumasaka T., Akao Y., Tanaka N. Structural insight of human DEAD-box protein rck/p54 into its substrate recognition with conformational changes. Genes Cells 2006, 11:439-452.
9. Iio A., Takagi T., Miki K., Naoe T., Nakayama A., Akao Y. DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells. Biochim. Biophys. Acta 2013, 1829:1102-1110.
10. Lee Y.S., Dutta A. MicroRNAs in cancer. Annu. Rev. Pathol. 2009, 4:199-227.
11. Goel A., Boland C.R. Epigenetics of colorectal cancer. Gastroenterology 2012, 143:1442-1460. (e1441).
12. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009, 10:704-714.
13. Makeyev E.V., Zhang J., Carrasco M.A., Maniatis T. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol. Cell 2007, 27:435-448.
14. Maiorano N.A., Mallamaci A. The pro-differentiating role of miR-124: indicating the road to become a neuron. RNA Biol. 2010, 7:528-533.
15. Xia H., Cheung W.K., Ng S.S., Jiang X., Jiang S., Sze J., Leung G.K., Lu G., Chan D.T., Bian X.W., Kung H.F., Poon W.S., Lin M.C. Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells. J. Biol. Chem. 2012, 287:9962-9971.
16. Furuta M., Kozaki K.I., Tanaka S., Arii S., Imoto I., Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010, 31:766-776.
17. Taniguchi K., Sugito N., Kumazaki M., Shinohara H., Yamada N., Nakagawa Y., Ito Y., Otsuki Y., Uno B., Uchiyama K., Akao Y. MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer. Cancer Lett. 2015, 363:17-27.
18. Taniguchi K., Ito Y., Sugito N., Kumazaki M., Shinohara H., Yamada N., Nakagawa Y., Sugiyama T., Futamura M., Otsuki Y., Yoshida K., Uchiyama K., Akao Y. Organ-specific PTB1-associated microRNAs determine expression of pyruvate kinase isoforms. Sci. Rep. 2015, 5:8647.
19. Noguchi T., Inoue H., Tanaka T. The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. J. Biol. Chem. 1986, 261:13807-13812.
20. Christofk H.R., Vander Heiden M.G., Harris M.H., Ramanathan A., Gerszten R.E., Wei R., Fleming M.D., Schreiber S.L., Cantley L.C. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008, 452:230-233.
21. Lim J.Y., Yoon S.O., Seol S.Y., Hong S.W., Kim J.W., Choi S.H., Cho J.Y. Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancer. World J. Gastroenterol. 2012, 18:4037-4043.
22. Chen M., Zhang J., Manley J.L. Turning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA. Cancer Res. 2010, 70:8977-8980.
23. Akao Y., Nakagawa Y., Hirata I., Iio A., Itoh T., Kojima K., Nakashima R., Kitade Y., Naoe T. Role of anti-oncomirs miR-143 and -145 in human colorectal tumors. Cancer Gene Ther. 2010, 17:398-408.
24. Shinohara H., Taniguchi K., Kumazaki M., Yamada N., Ito Y., Otsuki Y., Uno B., Hayakawa F., Minami Y., Naoe T., Akao Y. Anti-cancer fatty-acid derivative induces autophagic cell death through modulation of PKM isoform expression profile mediated by bcr-abl in chronic myeloid leukemia. Cancer Lett. 2015, 360:28-38.
25. Takagi T., Iio A., Nakagawa Y., Naoe T., Tanigawa N., Akao Y. Decreased expression of microRNA-143 and -145 in human gastric cancers. Oncology 2009, 77:12-21.
26. Nakagawa Y., Akao Y., Taniguchi K., Kamatani A., Tahara T., Kamano T., Nakano N., Komura N., Ikuno H., Ohmori T., Jodai Y., Miyata M., Nagasaka M., Shibata T., Ohmiya N., Hirata I. Relationship between expression of onco-related miRNAs and the endoscopic appearance of colorectal tumors. Int. J. Mol. Sci. 2015, 16:1526-1543.
27. Yeung S.J., Pan J., Lee M.H. Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer. Cell. Mol. Life Sci. 2008, 65:3981-3999.
28. David C.J., Chen M., Assanah M., Canoll P., Manley J.L. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 2010, 463:364-368.
29. Akao Y., Yoshida H., Matsumoto K., Matsui T., Hogetu K., Tanaka N., Usukura J. A tumour-associated DEAD-box protein, rck/p54 exhibits RNA unwinding activity toward c-myc RNAs in vitro. Genes Cells 2003, 8:671-676.
30. Saito K., Kondo E., Matsushita M. MicroRNA 130 family regulates the hypoxia response signal through the P-body protein DDX6. Nucleic Acids Res. 2011, 39:6086-6099.
31. Akao Y., Nakagawa Y., Naoe T. MicroRNA-143 and -145 in colon cancer. DNA Cell Biol. 2007, 26:311-320.
32. Kamatani A., Nakagawa Y., Akao Y., Maruyama N., Nagasaka M., Shibata T., Tahara T., Hirata I. Downregulation of anti-oncomirs miR-143/145 cluster occurs before APC gene aberration in the development of colorectal tumors. Med. Mol. Morphol. 2013, 46:166-171.
33. Ando T., Yoshida T., Enomoto S., Asada K., Tatematsu M., Ichinose M., Sugiyama T., Ushijima T. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int. J. Cancer 2009, 124:2367-2374.
34. Lin F., Wang R., Shen J.J., Wang X., Gao P., Dong K., Zhang H.Z. Knockdown of RCK/p54 expression by RNAi inhibits proliferation of human colorectal cancer cells in vitro and in vivo. Cancer Biol. Ther. 2008, 7:1669-1676.
35. Gao X., Wang H., Yang J.J., Liu X., Liu Z.R. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol. Cell 2012, 45:598-609.
36. Yang W., Xia Y., Ji H., Zheng Y., Liang J., Huang W., Gao X., Aldape K., Lu Z. Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation. Nature 2011, 480:118-122.
37. Jeon S.M., Chandel N.S., Hay N. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 2012, 485:661-665.
38. Carracedo A., Cantley L.C., Pandolfi P.P. Cancer metabolism: fatty acid oxidation in the limelight. Nat. Rev. Cancer 2013, 13:227-232.